Peregrine Capital Management LLC Adaptive Biotechnologies Corp Transaction History

Peregrine Capital Management LLC

$3.09 Billion
Q3 2025

A detailed history of Peregrine Capital Management LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Peregrine Capital Management LLC holds 522,802 shares of ADPT stock, worth $7.37 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

522,802

Previous 702,711 25.6%

Holding current value

$7.37 Million

Previous $8.19 Million 4.46%

% of portfolio

0.25%

Previous 0.27%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 23, 2025	SELL	$10.24 - $14.96 $1.84 Million - $2.69 Million	-179,909 Reduced 25.6%	522,802 $7.82 Million
Q2 2025 Aug 01, 2025	BUY	$6.83 - $12.16 $4.8 Million - $8.54 Million	702,711 New	702,711 $8.19 Million
Q1 2024 Apr 26, 2024	BUY	$2.88 - $4.8 $224 - $374	78 Added 0.02%	375,716 $1.21 Million
Q4 2023 Jan 26, 2024	SELL	$3.46 - $5.33 $222,536 - $342,809	-64,317 Reduced 14.62%	375,638 $1.84 Million
Q3 2023 Oct 19, 2023	SELL	$5.07 - $8.44 $138,568 - $230,673	-27,331 Reduced 5.85%	439,955 $2.4 Million

Q2 2023 Jul 26, 2023	SELL	$6.19 - $8.78 $674 - $957	-109 Reduced 0.02%	467,286 $3.14 Million
Q1 2023 Apr 26, 2023	BUY	$7.8 - $10.11 $1.56 Million - $2.02 Million	199,764 Added 74.64%	467,395 $4.13 Million
Q4 2022 Jan 10, 2023	SELL	$6.26 - $9.34 $69,486 - $103,674	-11,100 Reduced 3.98%	267,631 $2.05 Million
Q3 2022 Oct 26, 2022	SELL	$6.5 - $12.67 $98,943 - $192,862	-15,222 Reduced 5.18%	278,731 $1.99 Million
Q2 2022 Jul 20, 2022	SELL	$6.4 - $14.73 $154,828 - $356,348	-24,192 Reduced 7.6%	293,953 $2.38 Million
Q1 2022 Apr 27, 2022	SELL	$10.12 - $28.9 $215,717 - $616,032	-21,316 Reduced 6.28%	318,145 $4.42 Million
Q4 2021 Jan 31, 2022	BUY	$25.17 - $36.85 $1.56 Million - $2.29 Million	62,118 Added 22.4%	339,461 $9.53 Million
Q3 2021 Nov 02, 2021	SELL	$30.02 - $39.87 $1.34 Million - $1.78 Million	-44,578 Reduced 13.85%	277,343 $9.43 Million
Q2 2021 Aug 03, 2021	BUY	$32.22 - $44.59 $1.21 Million - $1.68 Million	37,628 Added 13.24%	321,921 $13.2 Million
Q1 2021 May 11, 2021	SELL	$37.26 - $67.74 $466,234 - $847,630	-12,513 Reduced 4.22%	284,293 $11.4 Million
Q4 2020 Jan 19, 2021	SELL	$45.01 - $65.47 $1.37 Million - $1.99 Million	-30,424 Reduced 9.3%	296,806 $17.6 Million
Q3 2020 Oct 20, 2020	SELL	$35.79 - $48.81 $1.64 Million - $2.24 Million	-45,817 Reduced 12.28%	327,230 $15.9 Million
Q2 2020 Jul 30, 2020	SELL	$24.95 - $48.38 $312,947 - $606,830	-12,543 Reduced 3.25%	373,047 $18 Million
Q1 2020 Apr 17, 2020	BUY	$16.96 - $34.16 $1.53 Million - $3.08 Million	90,041 Added 30.47%	385,590 $10.7 Million
Q4 2019 Jan 16, 2020	BUY	$24.56 - $32.8 $7.26 Million - $9.69 Million	295,549 New	295,549 $8.84 Million

Others Institutions Holding ADPT

# of Institutions

289

Shares Held

147M

Call Options Held

23.5K

Put Options Held

33.3K

View Full List

About Adaptive Biotechnologies Corp

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $2.01B
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

More about ADPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Peregrine Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peregrine Capital Management LLC with notifications on news.

Account

Peregrine Capital Management LLC Adaptive Biotechnologies Corp Transaction History